Mynosys Cellular Devices, Inc. Secures $25 Million Investment From Decheng Capital; Names Veteran Ophthalmic Executive Rob Thornhill as CEO

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2OAKyLC
via IFTTT